BOEHRINGER INGELHEIM ESPAÑA, S.A.
Track this competitor Create a free account to be notified when it wins a contract.
- Contracts won
- 4
- Amount won alone
- €2,614,400 excl. VAT
- Shared contracts
- 2 (multi-supplier framework agreements)
- Period
- 14 July 2026 – 19 October 2026
Its main clients
Where and what
Supplies · 4
Its contracts coming to an end
So many opportunities to take over these contracts when they are re-tendered.
| Planned end | Contract | Current holder | Amount |
|---|---|---|---|
| 31 August 2027 re-tender around March 2027 |
Suministro de tenecteplasa 10.000 unidades (50 mg) polvo y disolvente para solución inyectable y de idarucizumab 2,5 g/50 ml solución inyectable y para perfusión 2 viales de 50 ml, ambos de distribucion exclusiva por el laboratorio boehringer ingelheim, con destino al servicio de farmacia del summa 112 de madrid
SERVICIO DE URGENCIAS MÉDICAS DE MADRID - SUMMA 112 |
BOEHRINGER INGELHEIM ESPAÑA SA 1 bid received |
€148,333 |
| 14 April 2028 re-tender around October 2027 |
26Far019 b)suministro de medicamentos "exclusivos" (i)
CONSORCIO CORPORACIÓ SANITÀRIA PARC TAULÍ DE SABADELL |
BAYER HISPANIA S.L.U. BOEHRINGER INGELHEIM ESPAÑA, S.A. CASEN RECORDATI, S.L. Esteve Pharmaceuticals, S.A. EUROMED PHARMA SPAIN SL GLAXOSMITHKLINE, S.A. INCYTE BIOSCIENCES IBERIA, S.L. JANSSEN CILAG S.A. 1 bid received |
€540,765 |
Contracts won
Source: contract award notices published on TED (Publications Office of the European Union), above the EU thresholds. Contracts published only in Belgium are not included yet.